Skip to main content
Screener/Healthcare/Biotechnology

VYNE — VYNE Therapeutics Inc.

NASDAQ
$0.52-0.40 (-43.45%)
Penny StockUnder $1Under $5Healthcare
$0.28
$1.59
$0.48
$0.55
EPS (TTM)$-0.48
P/E Ratio-1.03
Dividend Yield—
Market Cap$9.8M
Volume2.40M
Prev Close$0.92
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$86K-$3.6M$-0.0893.0%-4168.6%
Q4 '25$130K-$4.8M$-0.1096.2%-3720.8%
Q3 '25$169K-$7.3M$-0.17100.0%-4307.7%
Q2 '25$69K-$5.8M$-0.13100.0%-8340.6%
Q1 '25$202K-$8.6M$-0.20100.0%-4262.9%
Q4 '24$84K-$12.0M$-0.28100.0%-14311.9%
Q3 '24$121K-$12.2M$-0.29100.0%-10047.1%
Q2 '24$198K-$9.4M$-0.22100.0%-4750.5%
Get Your Daily Market Recap